Zhou Research Group

The Structural Virology and Vaccinology Section (SVVS) seeks to uncover the fundamental mechanisms of viral entry, immune evasion, and antibody neutralization while leveraging structure- and AI-based design principles to develop innovative vaccines and therapeutics.

Group photo of the Structural Virology and Vaccinology Section Research Group
Credit: NIAID

Tongqing Zhou, Ph.D.

Chief, Structural Virology and Vaccinology Section
Chief, Structural Bioinformatics Core 
Earl-Stadtman Tenure-Track Investigator

Contact: tzhou@mail.nih.gov

Education:

Ph.D., 1994, Chinese Academy of Sciences, Beijing, China 
M.S., 1999, Wayne State University, Detroit, MI 
B.S., 1989, Wuhan University, Wuhan, China

Dr. Tongqing Zhou earned his Ph.D. in cell biology from the Chinese Academy of Sciences in 1994 and an M.Sc. in electronic and computer controlled systems from Wayne State University School of Engineering in 1999. From 1995 to 2001, he completed postdoctoral training at Wayne State University School of Medicine, specializing in structural biology. In 2001, Dr. Zhou joined the Dale and Betty...

Learn more about Tongqing Zhou, Ph.D.

Tongqing Zhou, Ph.D.

Li Ou, Ph.D.

Staff Scientist

Education:

Ph.D, Shanghai Institute of Organic Chemistry, Chinese Academy of Sciences

Languages Spoken: Chinese

Dr. Ou's research focuses on structure-based vaccine design targeting respiratory viruses and emerging infectious diseases. His primary interests lie in understanding viral protein structures and applying concepts such as conformation stabilization, epitope focusing, and nanoparticle delivery to facilitate vaccine development.

Learn more about Li Ou, Ph.D.

Zhantong Wang, Ph.D.

Scientist

Education:

Ph.D., Xiamen University

Languages Spoken: Mandarin

Dr. Zhantong Wang joined NIH as a special volunteer in 2014. After completing his Ph.D. at Xiamen University in 2016, he pursued postdoctoral research at NIH for three years. In 2021, he joined the Vaccine Research Center, where his primary focus is on developing nanoparticle vaccines.

Learn more about Zhantong Wang, Ph.D.

Content last reviewed on